Surgical Outcomes and Predicting Factors of Curative Resection in Patients with Hilar Cholangiocarcinoma: 10-Year Single-Institution Experience

Journal of Gastrointestinal Surgery

Volumn 16, Issue 9, 2012, Pages 1672-1679

  Cho, Min Soo ^a   Kim, Sung Hoon ^b   Park, Seung Woo ^a   Lim, Jin Hong ^a   Choi, Gi Hong ^a   Park, Joon Seong ^a   Chung, Jae Bock ^a   Kim, Kyung Sik ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Curative resection; Hilar cholangiocarcinoma; Liver optimization

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CANCER INVASION; FEMALE; HUMAN; INTRAHEPATIC BILE DUCT; LIVER RESECTION; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84865524627     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-012-1960-0     Document Type: Article

References (31)

1. Altemeier WA, Gall EA, Culbertson WR, Inge WW. Sclerosing carcinoma of the intrahepatic (hilar) bile ducts. Surgery 1966; 60(1): 191-200.
2. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. The American Journal of Medicine 1965; 38(2): 241-256.
3. Alvaro D, Crocetti E, Ferretti S, Bragazzi MC, Capocaccia R. Descriptive epidemiology of cholangiocarcinoma in Italy. Digestive and Liver Disease 2010; 42(7): 490-495.
4. Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. Journal of the National Cancer Institute 2006; 98(12): 873-875.
5. Lau SHY, Lau WY. Current therapy of hilar cholangiocarcinoma. Hepatobiliary and Pancreatic Diseases International 2012; 11(1): 12-17.
6. Igami T, Nishio H, Ebata T, et al. Surgical treatment of hilar cholangiocarcinoma in the new era: the Nagoya University experience. Journal of Hepato-Biliary-Pancreatic Surgery 2010; 17(4): 449-454.
7. Miyazaki M, Kimura F, Shimizu H, et al. Recent advance in the treatment of hilar cholangiocarcinoma: hepatectomy with vascular resection. Journal of Hepato-Biliary-Pancreatic Surgery 2007; 14(5): 463-468.
8. Ito F, Cho CS, Rikkers LF, Weber SM. Hilar cholangiocarcinoma: current management. Annals of Surgery 2009; 250(2): 210-218.
9. Kawakami H, Kuwatani M, Onodera M, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. Journal of Gastroenterology 2011; 46: 242-248.
10. Chung MJ, Lee KJ, Bang S, et al. Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer. Annals of Surgical Oncology 2011; 18(6): 1651-1656.
11. Hong YK, Choi SB, Lee KH, et al. The efficacy of portal vein embolization prior to right extended hemihepatectomy for hilar cholangiocellular carcinoma: a retrospective cohort study. European Journal of Surgical Oncology (EJSO) 2011; 37(3): 237-244.
12. Sano T, Kamiya J, Nagino M, et al. Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. Journal of Hepato-Biliary-Pancreatic Surgery 1999; 6(2): 101-107.
13. Miyazaki M, Ito H, Nakagawa K, et al. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery 1998; 123(2): 131-136.
14. Dinant S, Gerhards MF, Rauws EAJ, Busch ORC, Gouma DJ, van Gulik TM. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Annals of Surgical Oncology 2006; 13(6): 872-880.
15. Ito F, Agni R, Rettammel RJ, et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Annals of Surgery 2008; 248(2): 273-279.
16. Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Annals of Surgery 2003; 238(5): 720-727.
17. Dinant S, Gerhards MF, Busch ORC, Obertop H, Gouma DJ, van Gulik TM. The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma. HPB 2005; 7(4): 263-267.
18. Liu CL, Fan ST, Lo CM, Tso WK, Lam CM, Wong J. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. British Journal of Surgery 2006; 93(12): 1488-1494.
19. Ercolani G, Zanello M, Grazi GL, et al. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center. Journal of Hepato-Biliary-Pancreatic Sciences 2010; 17(3): 329-337.
20. Ikeyama T, Nagino M, Oda K, Ebata T, Nishio H, Nimura Y. Surgical approach to Bismuth type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Annals of Surgery 2007; 246(6): 1052-1057.
21. Figueras J, Codina-Barreras A, López-Ben S, et al. Major hepatectomies are safe in patients with cholangiocarcinoma and jaundice. Las hepatectomías mayores en pacientes con colangiocarcinoma e ictericia son seguras 2009; 86(5): 296-302.
22. Nagino M, Takada T, Miyazaki M, et al. Preoperative biliary drainage for biliary tract and ampullary carcinomas. Journal of Hepato-Biliary-Pancreatic Surgery 2008; 15(1): 25-30.
23. Abdel Wahab M, Fathy O, Elghwalby N, et al. Resectability and prognostic factors after resection of hilar cholangiocarcinoma. Hepato-Gastroenterology 2006; 53(67): 5-10.
24. Grandadam S, Compagnon P, Arnaud A, et al. Role of preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma type III. Annals of Surgical Oncology 2010; 17(12).
25. Hirano S, Kondo S, Tanaka E, et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. Journal of Hepato-Biliary-Pancreatic Surgery 2010; 17(4): 455-462.
26. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Annals of Surgery 2006; 243(3): 364-372.
27. Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa SI. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Annals of Surgery 2003; 238(1): 84-92.
28. Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Annals of Surgery 2003; 238(1): 73-83.
29. Hidalgo E, Asthana S, Nishio H, et al. Surgery for hilar cholangiocarcinoma: the Leeds experience. European Journal of Surgical Oncology 2008; 34(7): 787-794.
30. Pamecha V, Levene A, Grillo F, Woodward N, Dhillon A, Davidson BR. Effect of portal vein embolisation on the growth rate of colorectal liver metastases. British Journal of Cancer 2009; 100(4): 617-622.
31. De Graaf W, van Den Esschert JW, van Lienden KP, van Gulik TM. Induction of tumor growth after preoperative portal vein embolization: is it a real problem? Annals of Surgical Oncology 2009; 16(2): 423-430.